BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8093038)

  • 1. Characterization of the proline-rich region of mouse MAPKAP kinase 2: influence on catalytic properties and binding to the c-abl SH3 domain in vitro.
    Plath K; Engel K; Schwedersky G; Gaestel M
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1188-94. PubMed ID: 8093038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
    Van Etten RA; Debnath J; Zhou H; Casasnovas JM
    Oncogene; 1995 May; 10(10):1977-88. PubMed ID: 7539119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product.
    Sudol M
    Oncogene; 1994 Aug; 9(8):2145-52. PubMed ID: 8035999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains.
    Chan DC; Bedford MT; Leder P
    EMBO J; 1996 Mar; 15(5):1045-54. PubMed ID: 8605874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homodimerization of the c-Abl protein tyrosine kinase.
    Wei L; Liu X; Yi YP; Li CF; Wang YL; Cao C
    Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):698-702. PubMed ID: 16285507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
    Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
    Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proline-rich domain in the gamma subunit of phosphodiesterase 6 mediates interaction with SH3-containing proteins.
    Morin F; Vannier B; Houdart F; Regnacq M; Berges T; Voisin P
    Mol Vis; 2003 Sep; 9():449-59. PubMed ID: 14502124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for SH3 domain directed binding and phosphorylation of Sam68 by Src.
    Shen Z; Batzer A; Koehler JA; Polakis P; Schlessinger J; Lydon NB; Moran MF
    Oncogene; 1999 Aug; 18(33):4647-53. PubMed ID: 10467411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.
    Oda T; Kujovich J; Reis M; Newman B; Druker BJ
    Oncogene; 1997 Sep; 15(11):1255-62. PubMed ID: 9315092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
    Pisabarro MT; Serrano L; Wilmanns M
    J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure analysis and solution studies of human Lck-SH3; zinc-induced homodimerization competes with the binding of proline-rich motifs.
    Romir J; Lilie H; Egerer-Sieber C; Bauer F; Sticht H; Muller YA
    J Mol Biol; 2007 Feb; 365(5):1417-28. PubMed ID: 17118402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity.
    Juang JL; Hoffmann FM
    Oncogene; 1999 Sep; 18(37):5138-47. PubMed ID: 10498863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28.
    Marengère LE; Okkenhaug K; Clavreul A; Couez D; Gibson S; Mills GB; Mak TW; Rottapel R
    J Immunol; 1997 Oct; 159(7):3220-9. PubMed ID: 9317120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-terminal SH3 domain of p67phox binds its natural ligand in a reverse orientation.
    Finan P; Koga H; Zvelebil MJ; Waterfield MD; Kellie S
    J Mol Biol; 1996 Aug; 261(2):173-80. PubMed ID: 8757285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MAP kinase-activated protein kinase 2 contains a proline-rich SH3-binding domain.
    Engel K; Plath K; Gaestel M
    FEBS Lett; 1993 Dec; 336(1):143-7. PubMed ID: 8262198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the activity of SRC and Abl tyrosine protein kinases by the binding of the Wiskott-Aldrich syndrome protein.
    Schulte RJ; Sefton BM
    Biochemistry; 2003 Aug; 42(31):9424-30. PubMed ID: 12899629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
    Reichman C; Singh K; Liu Y; Singh S; Li H; Fajardo JE; Fiser A; Birge RB
    Oncogene; 2005 Dec; 24(55):8187-99. PubMed ID: 16158059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the specificity of Src homology 3 domain--ligand interactions with alkaline phosphatase fusion proteins.
    Yamabhai M; Kay BK
    Anal Biochem; 1997 Apr; 247(1):143-51. PubMed ID: 9126384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
    Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM
    Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.